Back to Search Start Over

Time course of response to estradiol replacement in ovariectomized mice: Brain apolipoprotein E and synaptophysin transiently increase and glial fibrillary acidic protein is suppressed

Authors :
McAsey, Mary E.
Cady, Craig
Jackson, Lindsay M.
Li, Miao
Randall, Shari
Nathan, Britto P.
Struble, Robert G.
Source :
Experimental Neurology. Jan2006, Vol. 197 Issue 1, p197-205. 9p.
Publication Year :
2006

Abstract

Abstract: The current study examined the effect of long-term estradiol replacement in ovariectomized mice. Estradiol-17β (E2) pellets or vehicle pellets were implanted at the time of ovariectomy (OVX) in young adult female mice. Five mice from each group were sacrificed at 5, 14, 28 and 49 days after OVX and pellet replacement. Western blotting of homogenates from somatosensory cortex, hippocampus, olfactory bulb and cerebellum was performed to obtain concentrations of glial fibrillary acidic protein (GFAP), apolipoprotein E (apoE) and synaptophysin (SYN). At 5 days after OVX, GFAP levels were not affected by E2 replacement. In contrast to GFAP, synaptophysin and apoE concentrations were significantly elevated by 15% and 25%, respectively, in the E2-replaced group compared to the vehicle-replaced group at 5 days but by 14 days concentrations were equivalent. Late in the time course of this study, at 49 days, GFAP concentrations were higher in the E2-deprived mice but did not increase in the E2-replaced group. Immunocytochemistry for GFAP confirmed this observation. Of note was that these effects occurred in all four brain regions measured. These observations suggest that estradiol is able to suppress reactive gliosis. In addition, E2 replacement in OVX mice is associated with transiently higher levels of apoE and synaptophysin. [Copyright &y& Elsevier]

Details

Language :
English
ISSN :
00144886
Volume :
197
Issue :
1
Database :
Academic Search Index
Journal :
Experimental Neurology
Publication Type :
Academic Journal
Accession number :
19308532
Full Text :
https://doi.org/10.1016/j.expneurol.2005.09.008